Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06575712 · ClinicalTrials.gov registry record · NA

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

A NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
177
Enrollment target
1
Study location

NCT06575712 is a NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy that is actively recruiting participants, run by Duke University. The registered enrollment target is 177 participants, above the 82-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06575712, a NA study of Hematopoietic Stem Cell Transplant and CAR T-Cell Therapy, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
177 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable HCT patients to effectively cope with symptoms (pain, fatigue, and stress) to improve their ability to engage in physical activity that can improve physical disability.

Interventions

  • BEHAVIORAL Step Up
  • OTHER Usual Care Plus (UC+)

Study Locations (1)

North Carolina

  • Duke Cancer Institute - Durham

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2025-04-21
Est. Completion 2028-08-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06575712

The ClinicalTrials.gov registry entry for NCT06575712 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 82-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (116% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 2 interventions - of which Step Up is the first listed.

NCT06575712 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06575712 about?

NCT06575712 is a clinical study titled "Coping Skills Training for Symptom Management and Daily Steps (Step Up)". The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable HCT patients to effectively cope with symptoms (pain, fatigue, and stress) to improve their ability to engage in physical activity that can i...

What is the current status of trial NCT06575712?

This trial is currently recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2025-04-21. Estimated completion is 2028-08-31.

What conditions does trial NCT06575712 study?

This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant, CAR T-Cell Therapy.

What interventions are being tested in trial NCT06575712?

The interventions under investigation include: Step Up (BEHAVIORAL), Usual Care Plus (UC+) (OTHER).

Who is sponsoring clinical trial NCT06575712?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06575712 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic Stem Cell Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.